Cannabics Pharmaceuticals Inc. CNBX , is dedicated to the development of personalized diagnostic tools to provide supportive data for practitioners and patients regarding cannabinoid based cancer therapy. The Company s R amp D is based in Israel, where it is fully licensed by the Ministry of Health and involves both scientific and current medical clinical studies which are registered with the US NIH. Cannabics is now creating tailored therapies for cancer patients, utilizing advanced Liquid Biopsy and HTS technology along with personalized bioinformatics tools. Cannabics research is devoted to the discovery of cannabinoid compounds targeted to specific cancers based on the confluence of cutting edge technologies and personalized bioinformatic markers.
Quote | Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX)
Last: | $0.0058 |
---|---|
Change Percent: | 3.43% |
Open: | $0.00676 |
Close: | $0.0058 |
High: | $0.007 |
Low: | $0.0058 |
Volume: | 27,132 |
Last Trade Date Time: | 07/19/2024 03:00:00 am |
News | Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX)
CNBX Pharmaceuticals Inc (CNBX) is expected to report for Q1 2003
CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma PR Newswire REHOVOT, Israel and BETHESDA, MD , Nov. 8, 2022 /PRNewswire/ -- CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader i...
Message Board Posts | Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX)
Subject | By | Source | When |
---|---|---|---|
$CNBX $CNBX Pharmaceuticals Inc (QB) | mick | investorshub | 04/30/2023 11:24:50 PM |
I wonder who they are ;) | AKthisistheone | investorshub | 04/28/2023 1:03:18 PM |
Not everyone, someone is buying the shares that | Gnarlyman | investorshub | 04/28/2023 12:19:49 PM |
I'm assuming everybody sold here? | AKthisistheone | investorshub | 04/27/2023 7:06:20 PM |
or one pump crew | SILVERSURFER4263 | investorshub | 04/26/2023 8:38:57 PM |
News, Short Squeeze, Breakout and More Instantly...
Cannabics Pharmaceuticals Inc Company Name:
CNBX Stock Symbol:
OTCMKTS Market:
Cannabics Pharmaceuticals Inc Website:
CNBX Pharmaceuticals Inc (CNBX) is expected to report for Q1 2003
CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma PR Newswire REHOVOT, Israel and BETHESDA, MD , Nov. 8, 2022 /PRNewswire/ -- CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader i...
CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy PR Newswire REHOVOT, Israel and BETHESDA, MD. , Oct. 18, 2022 /PRNewswire/ -- CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of...